Daily non-political popular news in brief.

Restoring sight, advances in fertility treatments and better visibility for pilots at FIO

Frontiers in Optics 2007, the 91st Annual Meeting of the Optical Society of America, will be held from Sept. 16-20 in San Jose, Calif. Following are a few of the many technical highlights to be discussed at the meeting: •Restoring Sight, One Pixel at a Time•Near-Infrared LIDAR Helps Pilots•Better, Stronger, Faster: High-Throughput Sperm Sorting •Detecting Malaria with Light•Gigantic Photoresponse Can Speed Up Optical Switches for Faster Internet Speeds •Explaining a 21st Century Version of Young's Experiment

Read more »

Keywords: restoring, sight, advances, fertility, treatments, visibility, pilots, fio, advance, treatment, pilot

« Previous | Next »

Similar news on "Restoring sight, advances in fertility treatments and better visibility for pilots at FIO":

1. Fresh use of targeted therapy advances treatment of early HER2-positive breast cancer
   11-16-2006 · EurekAlert!
   The news that the world's first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer "highlights a truly significant advance in the management of breast cancer," says Edith Perez, M.D., director of Mayo Clinic's Breast Clinic in Jacksonville, Florida.
   Similar news · Read more »
   
2. New treatments have major impact on heart failure rates
   05-01-2007 · EurekAlert!
   Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
   Similar news · Read more »
   
3. Insights into anemia control in dialysis patients
   07-11-2007 · EurekAlert!
   Anemia is one of the most frequent complications of hemodialysis, and its correction is an important factor in restoring a tolerable quality of life to dialysis-dependent patients. Treatment with drugs called erythropoiesis-stimulating agents (ESAs), which stimulate the bone marrow to produce red blood cells, have been a major advance in the treatment of the anemia (low levels of red blood cells or hemoglobin, which carries oxygen in the blood) in chronic kidney disease (CKD).
   Similar news · Read more »
   
4. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
   12-26-2007 · EurekAlert!
   In the latest edition of the New England Journal of Medicine, Eric Hoffman, PhD, posits that the results of a clinical trial involving a new treatment for Duchenne muscular dystrophy provides a proof-of-principle for personalized molecular medicine. He writes that advances allowing for systemic delivery of such drugs and provide proof of no long term toxicity for recipients are necessary but will likely come in short order. Moving forward, FDA regulations will prove critical for appropriate labeling and marketing of such personalized treatments.
   Similar news · Read more »
   
5. Ireland Cancer Center researchers advance lung cancer treatment
   04-23-2007 · EurekAlert!
   Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
   Similar news · Read more »
   
6. Accuracy of thyroid hormone testing improved with state-of-the-art test
   07-25-2007 · EurekAlert!
   Researchers at Georgetown University Medical Center have developed a fast and accurate way to measure a major hormone released by the thyroid gland -- an advance they say may help in the treatment of many women who have overactive or underactive thyroid glands.
   Similar news · Read more »
   
7. Standard therapy more effective than diabetes drug in helping women with PCOS achieve pregnancy
   02-07-2007 · EurekAlert!
   Metformin, a drug used to treat diabetes and once thought to have great promise in overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less effective than the standard fertility drug treatment, clomiphene, according to researchers from the University of Pennsylvania School of Medicine and the National Institutes of Health Reproductive Medicine research network.
   Similar news · Read more »
   
8. Germany's embryo protection law is 'killing embryos rather than protecting them'
   07-04-2007 · EurekAlert!
   Instead of preserving life, Germany's embryo protection law has had the unintended consequence of increasing the number of fetuses killed after fertility treatment, according to new figures presented at the European Society of Human Reproduction and Embryology. A representative of the German IVF registry has called for the law to be changed urgently to ensure that this situation does not continue.
   Similar news · Read more »
   
9. Tailored treatments: Promising designer drug provides new insight into cancer biology
   11-13-2006 · EurekAlert!
   Scientists are making progress toward unraveling the molecular mysteries that underlie cancer progression and treatment resistance. Two studies in the November 2006 issue of the journal Cancer Cell, published by Cell Press, provide mechanistic details that may explain why the small-molecule chemical ABT-737 is emerging as a unique and effective anticancer agent.
   Similar news · Read more »
   
10. Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
    12-14-2006 · EurekAlert!
    Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute, who first isolated cancer stem cells in adult brain tumors in 2004, have now found these cells to be highly resistant to chemotherapy and other treatments. Even if a tumor is almost completely obliterated, it will regenerate from the surviving cancer stem cells and be even more resistant to treatment than before.
    Similar news · Read more »